Making it Personal: Managing Chronic Symptoms in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Not Applicable

• Conditions: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome; Other - Conditions of unknown or disputed aetiology (such as chronic fatigue syndrome/myalgic encephalomyelitis)

• Registration Number: ACTRN12618001898246
• Lead Sponsor: The University of Queensland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-11-22
• Last Update Posted: 28 June 2021

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Adults 18 years or older with a medical diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Individuals are not excluded on the basis of their gender, age or overall health status.

Exclusion Criteria

Individuals under 18 years old. Individuals who have not received a medical diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The severity of physical fatigue measured on a 100mm visual analogue scale. The measure is designed specifically for this study. The data is analysed at the individual (n-of-1) level. [Three times per day (morning, afternoon and evening) for 6-12 weeks (duration of data collection period based on the preference of the participant).];The severity of cognitive fatigue measured on a 100mm visual analogue scale. The measure is designed specifically for this study. The data is analysed at the individual (n-of-1) level. [Three times per day (morning, afternoon and evening) for 6-12 weeks (duration of data collection period based on the preference of the participant).]

Secondary Outcome Measures

Name	Time	Method
The severity of a personally-relevant symptom (e.g. body pain, headaches, tinnitus, dizziness) selected by the participant at the start of the study measured on a 100mm visual analogue scale. The measure is designed specifically for this study. The data is analysed at the individual (n-of-1) level. If more than one symptom is selected by the participant, it will be analysed as another secondary outcome (i.e. not a composite measure). [Three times per day (morning, afternoon and evening) for 6-12 weeks (duration of data collection period based on the preference of the participant).]